This review focuses on the last decade evidence for a role of four members of the TNFRSF, Fas, TNFR1, LT-βR, and p75NTR in the death of motoneurons in ALS and how this new knowledge could be the basis of new therapeutic approaches in ALS. Here, TNFRSF1A is linked to amyotrophic lateral sclerosis.